Jinhua municipal central hospital

Jinhua, Zhejiang 321013

3 studies enrolling now · 6 studies all time

What they study most

Asthma, Immunoglobulin A Nephropathy (IgAN), Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC), Marginal Zone Lymphoma, Moderately to Severely Active Crohns Disease, Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage IIIB, Nonsmall Cell Lung Cancer, Stage IV, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma — Completed
• Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer — Completed